Request a Druggability Assessment
After we enter into a mutual NDA and receive a small amount your API, your no-cost, obligation-free assessment will be delivered in a few weeks, and will include a formulation and clinical supplies manufacturing development plan to optimize the progress of your preclinical compounds.
Your finished assessment will also contain:
- A preliminary API characterization (if needed)
- Budget and timeline expectations
- API requirements needed for your project
- Our recommendations for your targeted therapeutic application
What Information Will We Gather?
Please provide our team with any available information on your API, including any toxicology data. As part of your assessment, we will evaluate the physicochemical properties of your API for:
- Particle morphology
- Particle size and size distribution
- Hygroscopicity from 10-90% relative humidity
- Bulk and tap density/flow properties
- Crystal state evaluation and stress tests
- Suitability tests for solid dosage form manufacturing
- Thermal analysis
- Forced degredation
- Solubility in SGF, FaSSIF and FeSSIF
- Solubility in water
Reduce Your Risk With Solid Science
Protect Your Time
Protect Your Product
Protect Your Investment
Why Corealis?
We specialize in pharmaceutical oral solid dosage form development and Phase I/II and early Phase III clinical supply manufacturing. All of our services are done in-house, and what we do, we do very well.
Since 2005, here's what we're best known for:
- Reliability
- Flexibility
- Quality
- Regulatory compliance
- Personalized service